Mounjaro (tirzepatide) is a dual GIP/GLP-1 medication approved for type 2 diabetes, and it's one of the more expensive prescriptions a person can be asked to pay for out of pocket. Without any assistance, a month's supply can run several hundred to over a thousand dollars, depending on dose and pharmacy.
Because Mounjaro shares its active ingredient with Zepbound (Lilly's weight-management version of the same molecule), patients sometimes assume the assistance options and coverage rules are identical between the two. They aren't. Mounjaro's diabetes indication actually opens up coverage paths, like many Medicare Part D plans, that aren't available for weight-loss-only medications.
This guide breaks down each specific way to afford Mounjaro, who each option is actually for, and how to avoid applying to the wrong one.
Table of Contents
- Three Ways to Afford Mounjaro: A Side-by-Side Comparison
- The Mounjaro Savings Card
- The Lilly Cares Foundation Patient Assistance Program
- Why Mounjaro's Medicare Coverage Differs From Weight-Loss GLP-1s
- Mounjaro vs Zepbound: Why Indication Changes Everything
- LillyDirect Self-Pay Pricing
- Required Documents for Lilly Cares
- How to Apply, Step by Step
- How Long Approval Takes
- What to Do If You're Denied
- Frequently Asked Questions
Three Ways to Afford Mounjaro: A Side-by-Side Comparison
Before applying anywhere, figure out which category fits your situation. This decision alone saves most patients weeks of wasted paperwork.
| Program | Who It's For | Income-Based? | Requires Existing Coverage? |
|---|---|---|---|
| Mounjaro Savings Card | Commercially insured patients whose plan covers Mounjaro | No | Yes |
| Lilly Cares Foundation | Uninsured/underinsured, income-qualifying patients | Yes | No — designed for those without adequate coverage |
| LillyDirect Self-Pay | Patients paying cash, regardless of insurance status | No | No |
Quick gut check: If your insurance already covers Mounjaro but the copay is high, start with the savings card. If you have no coverage or a formulary exclusion, compare the Lilly Cares income requirements against LillyDirect's self-pay price before deciding which path to pursue.
The Mounjaro Savings Card
This program is a copay reduction tool, not a source of free medication. It only works when your insurance plan has already agreed to cover Mounjaro in some form.
| Feature | Detail |
|---|---|
| Who Qualifies | Commercially insured patients with Mounjaro coverage on their plan |
| What It Reduces | Copay or coinsurance amount at the pharmacy |
| Income Requirement | None |
| Medicare/Medicaid | Not eligible — federal program restriction |
If your plan doesn't cover Mounjaro at all (a formulary exclusion, not just a high copay), the savings card won't help — you'll need a formulary exception, the Lilly Cares Foundation, or LillyDirect instead.
The Lilly Cares Foundation Patient Assistance Program
This is the income-based charitable track, separate from the savings card, intended for patients who don't have adequate prescription coverage at all.
| Feature | What It Means |
|---|---|
| Cost to Patient | Typically $0 for approved medication |
| Who Administers It | Lilly Cares Foundation, Inc. |
| Enrollment Period | Typically 12 months, then reapplication required |
| Underlying Requirement | No adequate prescription coverage + income eligibility + type 2 diabetes diagnosis |
Income Eligibility Guidelines
| Household Size | Approximate Income Threshold (~400% FPL) |
|---|---|
| 1 Person | ~$62,600 |
| 2 People | ~$84,600 |
| 3 People | ~$106,600 |
| 4 People | ~$128,600 |
Federal poverty level figures update annually and vary slightly for Alaska and Hawaii. These are approximate; confirm the exact current threshold when you apply.
Why Mounjaro's Medicare Coverage Differs From Weight-Loss GLP-1s
This is the single biggest difference between Mounjaro and its weight-management cousins. Because Mounjaro's FDA-approved use is treating type 2 diabetes, it fits within Medicare Part D's traditional coverage categories in a way that weight-loss-only medications historically have not.
| Medication | FDA-Approved Use | Typical Medicare Part D Coverage |
|---|---|---|
| Mounjaro | Type 2 Diabetes | Often Covered (subject to plan formulary and PA) |
| Zepbound | Chronic Weight Management | Not Covered for Weight Loss Alone |
Why this matters: A patient with type 2 diabetes prescribed Mounjaro has a meaningfully better shot at Medicare Part D coverage than a patient without diabetes seeking a tirzepatide product purely for weight loss, even though the medication itself is nearly identical.
Mounjaro vs Zepbound: Why Indication Changes Everything
Both products are made by Eli Lilly and share the same active ingredient, tirzepatide, but they are FDA-approved for different conditions. That single difference cascades into everything from formulary placement to Medicare eligibility to prior authorization criteria.
| Factor | Mounjaro | Zepbound |
|---|---|---|
| FDA-Approved Indication | Type 2 Diabetes | Chronic Weight Management |
| Typical Prior Auth Criteria | A1C, diabetes diagnosis, step therapy with metformin | BMI, comorbidity documentation |
| Medicare Part D | Often Covered | Generally Excluded for Weight Loss |
| Lilly Cares Eligibility | Requires diabetes diagnosis | Requires weight-management indication and criteria |
If your insurance denies Mounjaro because your chart shows a weight-management goal rather than a diabetes diagnosis, that's a documentation and indication issue, not necessarily a sign the medication itself isn't covered by your plan.
LillyDirect Self-Pay Pricing
Separate from both programs above, Lilly offers a self-pay purchasing channel through LillyDirect, giving patients a set cash price outside the insurance system entirely.
| Feature | Detail |
|---|---|
| Who It's For | Patients without adequate coverage, or who prefer paying cash |
| Income Requirement | None |
| Insurance Requirement | None — works independently of insurance status |
| How to Access | Directly through the LillyDirect platform with a valid prescription |
Self-pay pricing can be a reasonable bridge option while a prior authorization or Lilly Cares application is pending, since it doesn't require waiting on an approval decision the way the charity program does.
Required Documents for Lilly Cares
| Document | Purpose |
|---|---|
| Completed patient section of application | Confirms identity, address, household size and insurance status |
| Completed prescriber section of application | Confirms type 2 diabetes diagnosis and medical necessity |
| Proof of income | Recent tax return, pay stubs, or benefits statement |
| Proof of insurance status | Insurance card, denial letter, or evidence of no drug coverage |
| Valid prescription | Confirms dose and formulation requested |
Step-by-Step: How to Apply to Lilly Cares
Confirm your indication matches the program
Lilly Cares eligibility for Mounjaro is tied to a type 2 diabetes diagnosis — confirm this is documented in your chart before applying.
Request the application
Applications are available through the Lilly Cares Foundation's materials or by phone, and are often provided directly by your prescriber's office.
Complete the patient section
Fill in your personal information, household size, income, and current insurance status.
Have your prescriber complete their section
Your provider confirms your type 2 diabetes diagnosis, the prescribed dose, and medical necessity.
Attach income and insurance documentation
Include recent proof of income and documentation showing your lack of adequate prescription coverage.
Submit and await a decision
Applications are typically submitted by fax or mail. You'll receive written notification of approval or denial with next steps.
How Long Approval Takes
| Situation | Typical Timeframe |
|---|---|
| Mounjaro Savings Card (already covered by insurance) | Immediate at the pharmacy counter |
| LillyDirect self-pay | Immediate, order-dependent |
| Lilly Cares, complete application | 2–4 weeks |
| Lilly Cares, missing documents | Additional 2–3 weeks after resubmission |
Decision Tree: Which Program Should You Use?
Step 1: Does your insurance already cover Mounjaro, just with a high copay?
✔ Yes → Use the Mounjaro Savings Card if you have commercial insurance.
✖ No → Continue to Step 2.
Step 2: Is your household income within the Lilly Cares limit and do you have a documented type 2 diabetes diagnosis?
✔ Yes → Apply to the Lilly Cares Foundation.
✖ No → Continue to Step 3.
Step 3: Do you need medication now while other options are pending, or does neither program fit?
✔ Yes → Check LillyDirect self-pay pricing as a bridge or standalone option.
What to Do If You're Denied
| Reason for Denial | What It Means | Next Step |
|---|---|---|
| Income above Lilly Cares threshold | Household income exceeds the foundation's limit | Compare LillyDirect self-pay pricing against your insurance's cash price |
| Missing documentation | Application was incomplete | Resubmit with all required documents attached |
| No documented diabetes diagnosis | Chart reflects weight-management goals rather than type 2 diabetes | Discuss documentation with your prescriber, or ask about Zepbound-specific programs instead |
| Existing adequate coverage | Program considers your current insurance sufficient | Use the Mounjaro Savings Card instead, if commercially insured |
Alternative Assistance Options
| Resource | What It Offers |
|---|---|
| Independent Diabetes-Focused Foundations | Copay and supply assistance grants for qualifying diagnoses |
| State Pharmaceutical Assistance Programs | State-run supplemental drug coverage for eligible residents |
| Hospital or Clinic Charity Care Programs | Discounted or free medication access through your care site |
| 340B-Participating Clinics | Reduced-cost medication access for patients treated at qualifying clinics |
Common Mistakes That Delay Getting Affordable Mounjaro
- □ Using the Savings Card while enrolled in Medicare or Medicaid (not eligible).
- □ Applying to Lilly Cares without a documented type 2 diabetes diagnosis on file.
- □ Prescriber section left blank or unsigned.
- □ Income documentation doesn't match household size.
- □ Assuming Zepbound's coverage rules automatically apply to Mounjaro, or vice versa.
- □ Outdated income documents older than the program's accepted window.
- □ Renewal submitted after the enrollment period already lapsed.
Most of these issues are simple documentation mismatches. Confirming your diagnosis, insurance status, and correct program before applying avoids weeks of unnecessary delay.
Quick Checklist Before You Apply to Lilly Cares
| Checklist Item | Status |
|---|---|
| Confirmed the Savings Card or LillyDirect won't solve the issue first | ☐ |
| Type 2 diabetes diagnosis documented | ☐ |
| Patient section fully completed | ☐ |
| Prescriber section signed and completed | ☐ |
| Recent proof of income attached | ☐ |
| Proof of insurance status attached | ☐ |
Bottom Line
Affording Mounjaro comes down to matching your specific insurance and income situation to the right program. Commercially insured patients with coverage already in place should start with the Mounjaro Savings Card. Uninsured or underinsured patients with a documented type 2 diabetes diagnosis and qualifying income should apply to the Lilly Cares Foundation. Anyone who needs a bridge option, or doesn't fit either program, can check LillyDirect's self-pay pricing.
Because Mounjaro's diabetes indication gives it a real shot at Medicare Part D coverage — unlike weight-loss-only GLP-1 medications — Medicare patients specifically should push for that coverage path first, with prior authorization documentation, before assuming they're stuck paying full price.
Frequently Asked Questions
Eligibility for the Lilly Cares Foundation generally requires being a U.S. resident with a type 2 diabetes diagnosis, having no adequate prescription drug coverage for Mounjaro, and meeting household income limits based on the federal poverty level.
Many Medicare Part D plans cover Mounjaro when prescribed for type 2 diabetes, since that is its FDA-approved indication, though prior authorization and step therapy requirements still commonly apply.
The Mounjaro Savings Card reduces out-of-pocket costs for commercially insured patients whose plan already covers Mounjaro, while the Patient Assistance Program provides the medication at no cost to eligible uninsured or underinsured, income-qualifying patients.
Mounjaro and Zepbound both contain tirzepatide and are made by Eli Lilly, but Mounjaro is FDA-approved for type 2 diabetes while Zepbound is FDA-approved for chronic weight management, which means they can have different insurance coverage rules even though the medication itself is similar.
Lilly offers self-pay purchasing options through LillyDirect for eligible patients, providing a set cash price that can be lower than the full list price for those without adequate insurance coverage.
No. Federal restrictions generally prevent Medicare and Medicaid beneficiaries from using manufacturer copay cards. Medicare patients should instead pursue Part D coverage directly or check Lilly Cares Foundation eligibility.
Common reasons include missing step therapy documentation (such as a prior metformin trial), an incomplete prior authorization submission, or a formulary exclusion at the plan level. Reviewing the specific denial reason with your prescriber is the fastest way to identify next steps.
Yes. Enrollment is typically granted for a set period, often around 12 months, after which you must reapply and resubmit updated income and insurance documentation.
If your household income exceeds the foundation's threshold, LillyDirect self-pay pricing and independent diabetes-focused foundations are worth exploring as alternatives, since neither requires meeting the same income criteria.
No. Because each product has its own approved indication and program criteria, switching prescriptions generally means starting a new application process for whichever program matches the new medication.
A change in insurance status is exactly the kind of situation the Lilly Cares Foundation is designed for. In the meantime, LillyDirect self-pay pricing can serve as a bridge option while your application is processed.
How We Researched This Guide
References
- Eli Lilly and Company. Mounjaro Savings Card, Lilly Cares Foundation, and LillyDirect Program Materials.
- U.S. Food and Drug Administration. Mounjaro and Zepbound Prescribing Information.
- U.S. Department of Health and Human Services. Federal Poverty Level Guidelines.
- Centers for Medicare & Medicaid Services. Medicare Part D Formulary and Coverage Determination Guidance.
- Partnership for Prescription Assistance. Patient Assistance Program Standards.
Related Resources
- Complete Prior Authorization Guide (2026)
- Humalog Patient Assistance Program
- Novo Nordisk Patient Assistance Program
- Wegovy Prior Authorization Requirements
- Ozempic Prior Authorization Requirements
Editorial Policy: Refill Relay content is researched using publicly available manufacturer patient assistance program materials, federal poverty guidelines, and standard industry application practices. Every article is reviewed for clarity, accuracy and usefulness before publication.